HIV treatment-as-prevention research at a crossroads

In light of changing WHO guidelines for HIV treatment, Till Bärnighausen and colleagues consider how large-scale HIV treatment-as-prevention trials can be adapted so that they can remain viable. Please see later in the article for the Editors' Summary

Saved in:
Bibliographic Details
Main Authors: Bärnighausen, Till (Author) , Eyal, Nir M. (Author) , Wikler, Daniel (Author)
Format: Article (Journal)
Language:English
Published: June 3, 2014
In: PLoS medicine
Year: 2014, Volume: 11, Issue: 6, Pages: e1001654
ISSN:1549-1676
DOI:10.1371/journal.pmed.1001654
Online Access:Verlag, Volltext: http://dx.doi.org/10.1371/journal.pmed.1001654
Verlag, Volltext: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001654
Get full text
Author Notes:Till Bärnighausen, Nir Eyal, Daniel Wikler
Description
Summary:In light of changing WHO guidelines for HIV treatment, Till Bärnighausen and colleagues consider how large-scale HIV treatment-as-prevention trials can be adapted so that they can remain viable. Please see later in the article for the Editors' Summary
Item Description:Gesehen am 05.03.2018
Physical Description:Online Resource
ISSN:1549-1676
DOI:10.1371/journal.pmed.1001654